Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
The short-term study is believed to be the first to evaluate both interventions combined for people with mental illness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback